DE69131047D1 - Pharmazeutische zusammensetzungen - Google Patents

Pharmazeutische zusammensetzungen

Info

Publication number
DE69131047D1
DE69131047D1 DE69131047T DE69131047T DE69131047D1 DE 69131047 D1 DE69131047 D1 DE 69131047D1 DE 69131047 T DE69131047 T DE 69131047T DE 69131047 T DE69131047 T DE 69131047T DE 69131047 D1 DE69131047 D1 DE 69131047D1
Authority
DE
Germany
Prior art keywords
release
pellets
pharmaceutical compositions
antagonist
phased
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69131047T
Other languages
English (en)
Inventor
Keith Marshall
William Thiele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
SmithKline Beecham Corp
Original Assignee
GlaxoSmithKline LLC
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC, SmithKline Beecham Corp filed Critical GlaxoSmithKline LLC
Application granted granted Critical
Publication of DE69131047D1 publication Critical patent/DE69131047D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69131047T 1990-12-05 1991-12-04 Pharmazeutische zusammensetzungen Expired - Lifetime DE69131047D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62287590A 1990-12-05 1990-12-05
PCT/US1991/009221 WO1992010173A1 (en) 1990-12-05 1991-12-04 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE69131047D1 true DE69131047D1 (de) 1999-04-29

Family

ID=24495857

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131047T Expired - Lifetime DE69131047D1 (de) 1990-12-05 1991-12-04 Pharmazeutische zusammensetzungen

Country Status (14)

Country Link
EP (1) EP0560937B1 (de)
JP (1) JPH06503577A (de)
KR (1) KR930702961A (de)
AT (1) ATE177945T1 (de)
AU (1) AU9164191A (de)
CA (1) CA2097495A1 (de)
DE (1) DE69131047D1 (de)
ES (1) ES2129444T3 (de)
IE (1) IE914207A1 (de)
MX (1) MX9102413A (de)
NZ (1) NZ240853A (de)
PT (1) PT99699A (de)
WO (1) WO1992010173A1 (de)
ZA (1) ZA919510B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761209A3 (de) * 1995-09-01 1998-02-04 J.B. Chemicals & Pharmaceuticals Ltd. Ranitidinformulierungen mit gesteuerter Freisetzung
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE19718012C1 (de) * 1997-04-29 1998-10-08 Jenapharm Gmbh Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe
CN102151247A (zh) * 2000-06-23 2011-08-17 生物计划公司 包含外消旋卡朵曲的干粉制剂
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
GB0403098D0 (en) 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
TWI350762B (en) 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP1802285B1 (de) 2004-10-21 2013-02-27 Aptalis Pharmatech, Inc. Geschmacksverdeckende pharmazeutische zusammensetzungen mit magenlöslichen porenbildnern
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
TWI471146B (zh) 2009-12-02 2015-02-01 Aptalis Pharma Ltd 菲索特芬那定（ｆｅｘｏｆｅｎａｄｉｎｅ）微膠囊及包含其之組合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
FR2655266B1 (fr) * 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.

Also Published As

Publication number Publication date
WO1992010173A1 (en) 1992-06-25
MX9102413A (es) 1994-01-31
NZ240853A (en) 1995-02-24
JPH06503577A (ja) 1994-04-21
EP0560937A1 (de) 1993-09-22
CA2097495A1 (en) 1992-06-06
EP0560937B1 (de) 1999-03-24
KR930702961A (ko) 1993-11-29
EP0560937A4 (en) 1993-10-13
AU9164191A (en) 1992-07-08
ZA919510B (en) 1992-10-28
ATE177945T1 (de) 1999-04-15
IE914207A1 (en) 1992-06-17
ES2129444T3 (es) 1999-06-16
PT99699A (pt) 1992-10-30

Similar Documents

Publication Publication Date Title
ATE177945T1 (de) Pharmazeutische zusammensetzungen
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
DE69738300D1 (de) Pharmazeutische zusammensetzungen mit verzoegerter freisetzung, die wasserunloesliche komplexverbindungen enthalten
ATE213629T1 (de) Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe
DE69613463D1 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
NO20053106L (no) Oral, analgesisk doseringsform med forlenget frigivelse.
ATA106594A (de) Pharmazeutische orale zusammensetzung enthaltend verbindungen der rapamycinklasse
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69833464D1 (de) Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-PyrazoloÄ1,5-bÜPyridazin Derivate
IT1289160B1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
ATE324872T1 (de) Orale pharmazeutische zusammensetzung mit verzögerter wirkstofffreigabe von protonenpumpen- hemmern
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
DE10084290T1 (de) Stabilisierte orale pharmazeutische Zusammensetzung, die Jodid und Jodat enthält und ein Verfahren zu deren Herstellung
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
ATE332698T1 (de) Pharmazeutische zusammenstellungen enthaltend einen p2t rezeptor antagonist und melagatran
BR0211198A (pt) Composições farmacêuticas e seu uso
ATA59499A (de) Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
NO911344L (no) Farmasoeytisk preparat med nitroglyserin til perkutan administrering.
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
ATE260094T1 (de) Mikronisierte bicyclische arzneistoffe enthaltende pharmazeutische zusammensetzungen
ATE195940T1 (de) Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Legal Events

Date Code Title Description
8332 No legal effect for de